CClinicalTrials.gg
Enrolling by invitationNCT06192654Updated Jan 5, 2024

Small Intestinal Submucosa Graft for Repair of Anterior Urethral Strictures

An interventional study of Small intestinal submucosa (SIS) graft urethroplasty and Autologous oral bucal mucosa graft urethroplasty in Urethral Stricture, Male, sponsored by Xiaoyong Zeng. Enrolling by invitation at 1 site in China. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-05.

Sponsored by Xiaoyong Zeng · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
18 Years and older
Sex
Male
01

Study summary

The field of research for this study is tissue engineering and the utilization of a small intestinal submucosa graft as a substitute biomaterial for conventional buccal mucosa in substitution urethroplasty of anterior urethral strictures.

Read the detailed description

Urethral stricture refers to the abnormal narrowing of the urethral lumen resulting from fibrosis that affects the urethral epithelium and underlying corpus spongiosum. The management of urethral stricture longer than 2 cm a major therapeutic challenge in clinics. Currently available surgical techniques require harvesting of grafts from autologous sites. However, there are numerous disadvantages associated with autografts, such as limited availability and variable quality, donor site morbidity, increased risk of surgical complications; thereby the application of this method is especially limited for large defects.

The hypothesis of this study is that the small intestinal submucosa graft can be used as an alternative biomaterial to buccal mucosa for substitution urethroplasty in urethral stricture patients. The aim of this study is to assess safety and efficacy of surgical treatment of patients with anterior urethral stricture using a small intestinal submucosa graft. The follow-up time for all patients in this study was 5 years. The follow-up regimen includes retrograde and pericatheter urethrography, voiding cystourethrography, uroflowmetry, cystoscopy, and voiding symptoms monitoring. Telephone follow-up will take place in between these assessments.

02

Conditions studied

  • Urethral Stricture, Male

Keywords

  • urethral stricture
03

In context

Urethral Stricture

68 studies on the registry are indexed under Urethral Stricture; 23 are open to participants now.

This study's planned enrollment of 10 is below the median of 60 across 53 interventional studies indexed under Urethral Stricture.

Browse Urethral Stricture studies →

Lead sponsor

This is the only study on the registry with Xiaoyong Zeng as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Patients signed informed consent form
  • Patients with a single, longer than 2.0 cm and shorter than or equal to 7.0 cm anterior urethral stricture
  • Patients undergoing substitution urethroplasty for urethral stricture.

Exclusion criteria

Exclusion Criteria:

  • Patients without surgical indication
  • Subtotal and total urethral strictures
  • Radiation therapy to the abdomen or pelvis
  • Lichen sclerosis related strictures
  • Patients with previous hypospadias repair
  • Neurogenic urinary tract disorders
  • Mental disorders
  • Patients with a known biologic sensitivity or a cultural aversion to the use of porcine materials.
  • Patients with severe dysfunction of heart, lung, liver, kidney and other important organs , endocrine system and blood system.
  • Patient with malignant tumor
  • Patient who cannot be regularly examined due to any circumstances
  • Any clinical state which does not ensure the safe implementation of study procedure (investigator's view)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Small intestinal submucosa (SIS) graft urethroplasty

    this group will use a small intestinal submucosa graft in urethroplasty.

    Procedure: Small intestinal submucosa (SIS) graft urethroplasty

  • Active comparator
    Autologous oral bucal mucosa graft urethroplasty

    this group will use an autologous oral bucal mucosa graft in urethroplasty.

    Procedure: Autologous oral bucal mucosa graft urethroplasty

Interventions

  • ProcedureSmall intestinal submucosa (SIS) graft urethroplasty

    Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. Instead of an autologous oral bucal mucosa graft, the small intestinal submucosa graft is sutured to the healty urethral area after incision of the urethra at the stricture location.

  • ProcedureAutologous oral bucal mucosa graft urethroplasty

    Standard technique of doing a substitution urethroplasty with no modification to the surgical steps. The autologous oral bucal mucosa graft is sutured to the healty urethral area after incision of the urethra at the stricture location.

06

What researchers measure

Primary outcomes

  1. Urethral patency

    A peri-urethrogram will be performed prior to catheter removal

    Time frame: 4 weeks post-surgery

Secondary outcomes

  1. Serious adverse events

    Frequency, type and severity of serious adverse events

    Time frame: 4 weeks post-surgery

  2. Voiding symptoms

    Participants are filling out the International Prostate Symptom Score (IPSS) questionnaire.

    Time frame: 2 months up-to 5 years post-surgery

  3. Urine flow

    Participants are undergoing an uroflowmetry. This test measures the volume of urine released from the body, the speed with which it is released, and how long the release takes.

    Time frame: 2 months up-to 5 years post-surgery

  4. Anatomic recurrence of urethral stricture observed by cystoscopy 、 Retrograde urethrography(RUG)、 Voiding cystourethrography(VCUG)

    Full assessment of the urethral lumen after the surgery

    Time frame: Through study completion, an average of up to 5 years

07

Study locations

1 site
  • Tongji hospital
    Wuhan, Hubei, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06192654
Lead sponsor
Xiaoyong Zeng
Responsible party
Xiaoyong Zeng (Professor, Tongji Hospital) — Sponsor-investigator
First posted
Jan 5, 2024
Start date
Nov 10, 2023
Primary completion
Oct 20, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Jan 5, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion